Literature DB >> 22481132

Patients' understanding of and responses to multiplex genetic susceptibility test results.

Kimberly A Kaphingst1, Colleen M McBride, Christopher Wade, Sharon Hensley Alford, Robert Reid, Eric Larson, Andreas D Baxevanis, Lawrence C Brody.   

Abstract

PURPOSE: Examination of patients' responses to direct-to-consumer genetic susceptibility tests is needed to inform clinical practice. This study examined patients' recall and interpretation of, and responses to, genetic susceptibility test results provided directly by mail.
METHODS: This observational study had three prospective assessments (before testing, 10 days after receiving results, and 3 months later). Participants were 199 patients aged 25-40 years who received free genetic susceptibility testing for eight common health conditions.
RESULTS: More than 80% of the patients correctly recalled their results for the eight health conditions. Patients were unlikely to interpret genetic results as deterministic of health outcomes (mean = 6.0, s.d. = 0.8 on a scale of 1-7, 1 indicating strongly deterministic). In multivariate analysis, patients with the least deterministic interpretations were white (P = 0.0098), more educated (P = 0.0093), and least confused by results (P = 0.001). Only 1% talked about their results with a provider.
CONCLUSION: Findings suggest that most patients will correctly recall their results and will not interpret genetics as the sole cause of diseases. The subset of those confused by results could benefit from consultation with a health-care provider, which could emphasize that health habits currently are the best predictors of risk. Providers could leverage patients' interest in genetic tests to encourage behavior changes to reduce disease risk.

Entities:  

Mesh:

Year:  2012        PMID: 22481132      PMCID: PMC3417078          DOI: 10.1038/gim.2012.22

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  37 in total

1.  Reading between the lines: direct-to-consumer advertising of genetic testing.

Authors:  S C Hull; K Prasad
Journal:  Hastings Cent Rep       Date:  2001 May-Jun       Impact factor: 2.683

2.  Limitations of direct-to-consumer advertising for clinical genetic testing.

Authors:  Sarah E Gollust; Sara Chandros Hull; Benjamin S Wilfond
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

3.  The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample.

Authors:  John R Crawford; Julie D Henry
Journal:  Br J Clin Psychol       Date:  2004-09

4.  The general public's understanding and perception of direct-to-consumer genetic test results.

Authors:  J W Leighton; K Valverde; B A Bernhardt
Journal:  Public Health Genomics       Date:  2011-06-30       Impact factor: 2.000

5.  Simulation study of confounder-selection strategies.

Authors:  G Maldonado; S Greenland
Journal:  Am J Epidemiol       Date:  1993-12-01       Impact factor: 4.897

6.  Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.

Authors:  Katherine M James; Clayton T Cowl; Jon C Tilburt; Pamela S Sinicrope; Marguerite E Robinson; Katrin R Frimannsdottir; Kristina Tiedje; Barbara A Koenig
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

7.  Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing.

Authors:  Kimberly A Kaphingst; Colleen M McBride; Christopher Wade; Sharon Hensley Alford; Lawrence C Brody; Andreas D Baxevanis
Journal:  J Med Internet Res       Date:  2010-09-29       Impact factor: 5.428

8.  Australian study on public knowledge of human genetics and health.

Authors:  C Molster; T Charles; A Samanek; P O'Leary
Journal:  Public Health Genomics       Date:  2008-10-15       Impact factor: 2.000

9.  Considerations for designing a prototype genetic test for use in translational research.

Authors:  C H Wade; C M McBride; S L R Kardia; L C Brody
Journal:  Public Health Genomics       Date:  2009-09-03       Impact factor: 2.000

10.  Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions.

Authors:  Colleen M McBride; Sharon Hensley Alford; Robert J Reid; Eric B Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Genet Med       Date:  2009-08       Impact factor: 8.822

View more
  71 in total

1.  Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).

Authors:  Sherry-Ann N Brown; Hayan Jouni; Tariq S Marroush; Iftikhar J Kullo
Journal:  Circ Cardiovasc Genet       Date:  2017-08

2.  Predictive genetic testing, risk communication, and risk perception: an international expert meeting in Berlin, Germany.

Authors:  Eva Fisher; Steffi Achilles; Holger Tönnies
Journal:  J Community Genet       Date:  2013-12-10

Review 3.  Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

Authors:  Susanne B Haga; Rachel Mills; Hayden Bosworth
Journal:  Patient Educ Couns       Date:  2014-06-21

4.  A primer in genomics for social and behavioral investigators.

Authors:  Erin Turbitt; Barbara B Biesecker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

5.  Does personal genome testing drive service utilization in an adult preventive medicine clinic?

Authors:  Ny Hoang; Robin Hayeems; Jill Davies; Shuye Pu; Syed Wasim; Lea Velsher; James Aw; Sébastien Chénier; Dimitri J Stavropoulos; Riyana Babul-Hirji; Rosanna Weksberg; Cheryl Shuman
Journal:  J Community Genet       Date:  2017-04-03

6.  Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study.

Authors:  Kevin Sweet; Shelly Hovick; Amy C Sturm; Tara Schmidlen; Erynn Gordon; Barbara Bernhardt; Lisa Wawak; Karen Wernke; Joseph McElroy; Laura Scheinfeldt; Amanda E Toland; J S Roberts; Michael Christman
Journal:  J Genet Couns       Date:  2016-12-05       Impact factor: 2.537

7.  The challenge of personal genomics in Germany.

Authors:  Effy Vayena; Barbara Prainsack
Journal:  Nat Biotechnol       Date:  2013-01       Impact factor: 54.908

8.  Teaching genomic counseling: preparing the genetic counseling workforce for the genomic era.

Authors:  Gillian W Hooker; Kelly E Ormond; Kevin Sweet; Barbara B Biesecker
Journal:  J Genet Couns       Date:  2014-02-08       Impact factor: 2.537

9.  Behavioral and psychosocial responses to genomic testing for colorectal cancer risk.

Authors:  Kristi D Graves; Kara-Grace Leventhal; Rachel Nusbaum; Yasmin Salehizadeh; Gillian W Hooker; Beth N Peshkin; Morgan Butrick; William Tuong; Jeena Mathew; David Goerlitz; Mary B Fishman; Peter G Shields; Marc D Schwartz
Journal:  Genomics       Date:  2013-04-11       Impact factor: 5.736

10.  Impact of delivery models on understanding genomic risk for type 2 diabetes.

Authors:  S B Haga; W T Barry; R Mills; L Svetkey; S Suchindran; H F Willard; G S Ginsburg
Journal:  Public Health Genomics       Date:  2014-02-27       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.